NASDAQ:INVA

Innoviva Stock Insider Trading

Healthcare > Biotechnology

Buy INVA

*Your capital is at risk

$21.70

+0.350 (+1.64%)

At Close: Jun 03, 2026

Innoviva Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -67.86. In total, the insiders bought 2.03M and sold 3.26M INVA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-67.86
● Buy	2.03M shares
● Sell	3.26M shares
70% Buy Activity Moderate Negative Correlation
Buy Signal Low Confidence May 04, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -67.86. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 24, 2025 Buy	Non-statutory Stock Option A-Award	Basso Stephen Chief Financial Officer	C-Suite Officer	100 831 Value: $1.82M
Feb 24, 2025 Buy	Common Stock A-Award	Zhen Marianne Chief Accounting Officer	Officer	8 938 Value: $161.6K
Feb 24, 2025 Buy	Non-statutory Stock Option A-Award	Zhen Marianne Chief Accounting Officer	Officer	30 300 Value: $547.8K
Feb 20, 2025 Sell	Common Stock F-InKind	Zhen Marianne Chief Accounting Officer	Officer	2 565 Value: $46.3K
Feb 20, 2025 Sell	Common Stock F-InKind	Basso Stephen Chief Financial Officer	C-Suite Officer	1 106 Value: $20.0K
Feb 20, 2025 Sell	Common Stock F-InKind	Basso Stephen Chief Financial Officer	C-Suite Officer	1 106 Value: $20.0K
Feb 20, 2025 Sell	Common Stock F-InKind	Zhen Marianne Chief Accounting Officer	Officer	2 565 Value: $46.3K
Nov 20, 2024 Sell	Common Stock F-InKind	Zhen Marianne Chief Accounting Officer	Officer	976 Value: $18.7K
Nov 20, 2024 Sell	Common Stock F-InKind	Zhen Marianne Chief Accounting Officer	Officer	976 Value: $18.7K
Nov 15, 2024 Buy	Common Stock A-Award	Basso Stephen Chief Financial Officer	C-Suite Officer	843 Value: $15.9K
Nov 15, 2024 Buy	Common Stock A-Award	Basso Stephen Chief Financial Officer	C-Suite Officer	843 Value: $15.9K
Nov 15, 2024 Buy	Common Stock A-Award	Zhen Marianne Chief Accounting Officer	Officer	300 Value: $6K
Nov 15, 2024 Buy	Common Stock A-Award	Zhen Marianne Chief Accounting Officer	Officer	300 Value: $6K
Aug 20, 2024 Sell	Common Stock F-InKind	Zhen Marianne Chief Accounting Officer	Officer	975 Value: $18.0K
Aug 20, 2024 Sell	Common Stock F-InKind	Zhen Marianne Chief Accounting Officer	Officer	975 Value: $18.0K
Jun 17, 2024 Buy	Common Stock A-Award	Srivastava Sapna Director	Director	13 923 Value: $225.0K
Jun 17, 2024 Buy	Non-statutory Stock Option A-Award	Srivastava Sapna Director	Director	10 000 Value: $161.6K
Jun 17, 2024 Buy	Common Stock A-Award	Small Derek A Director	Director	13 923 Value: $225.0K
Jun 17, 2024 Buy	Non-statutory Stock Option A-Award	Small Derek A Director	Director	10 000 Value: $161.6K
Jun 17, 2024 Buy	Common Stock A-Award	Schlesinger Sarah J. Director	Director	13 923 Value: $225.0K
Jun 17, 2024 Buy	Non-statutory Stock Option A-Award	Schlesinger Sarah J. Director	Director	10 000 Value: $161.6K
Jun 17, 2024 Buy	Common Stock A-Award	Odysseas Kostas D Director	Director	13 923 Value: $225.0K
Jun 17, 2024 Buy	Non-statutory Stock Option A-Award	Odysseas Kostas D Director	Director	10 000 Value: $161.6K
Jun 17, 2024 Buy	Common Stock A-Award	Haimovitz Jules Director	Director	13 923 Value: $225.0K
Jun 17, 2024 Buy	Non-statutory Stock Option A-Award	Srivastava Sapna Director	Director	10 000 Value: $161.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT INNOVIVA, INC

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY...

Read Full Profile Here